A phase Ib/II trial of perioperative intratumoral MVA-BN-brachyury (MVA) plus systemic PROSTVAC and atezolizumab (Atezo) for intermediate-risk and high-risk localized prostate cancer (AtezoVax)-MedSci.cn

A phase Ib/II trial of perioperative intratumoral MVA-BN-brachyury (MVA) plus systemic PROSTVAC and atezolizumab (Atezo) for intermediate-risk and high-risk localized prostate cancer (AtezoVax)

Maughan, BL; Sanchez, A; O'Neil, BB; Lowrance, WT; Dechet, CB; Albertson, DJ; Sirohi, D; Gupta, S; Swami, U; Agarwal, N

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (6):

科室
- - 订阅+
  - 更多科室
工具
服务